Aprea Therapeutics (APRE)
(Delayed Data from NSDQ)
$5.37 USD
-0.32 (-5.54%)
Updated Apr 23, 2024 03:57 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.78 |
EPS Last Quarter | -0.92 |
Last EPS Surprise | -64.29% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.38 |
Next Year | -0.96 |
EPS (TTM) | -3.99 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 0.60M | 0.60M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 0.60M | 0.60M |
Low Estimate | NA | NA | 0.60M | 0.60M |
Year ago Sales | 0.00M | 0.25M | 0.58M | 0.60M |
Year over Year Growth Est. | NA | NA | 2.92% | 0.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.78 | -0.81 | -2.38 | -0.96 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.78 | -0.81 | -2.38 | -0.96 |
High Estimate | -0.75 | -0.80 | -1.39 | -0.58 |
Low Estimate | -0.80 | -0.81 | -3.36 | -1.34 |
Year ago EPS | -1.34 | -0.87 | -3.95 | -2.38 |
Year over Year Growth Est. | 41.79% | 6.90% | 39.75% | 59.45% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 1 |
Down Last 60 Days | 1 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.78 | -0.81 | -2.38 | -0.96 |
7 Days Ago | -0.78 | -0.81 | -2.38 | -0.96 |
30 Days Ago | -0.20 | -0.22 | -1.56 | -1.10 |
60 Days Ago | -0.20 | -0.22 | -1.06 | -1.10 |
90 Days Ago | -0.20 | -0.22 | -1.06 | -1.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.78 | -0.81 | -2.38 | -0.96 |
Zacks Consensus Estimate | -0.78 | -0.81 | -2.38 | -0.96 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.92 | -0.86 | -0.87 | -1.34 | NA |
Estimate | -0.56 | -1.08 | -1.43 | -1.51 | NA |
Difference | -0.36 | 0.22 | 0.56 | 0.17 | 0.15 |
Surprise | -64.29% | 20.37% | 39.16% | 11.26% | 1.63% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more